SOD1 and amyotrophic lateral sclerosis: The current study provides crucial data that establishes for the first time the beneficial therapeutic effects of A-MultiPath-DCS in the SOD1-G93A mouse model of ALS and offers fundamental electrophysiological, cellular, and molecular characterization of the treatment effects.